Evidence map›Paper›PMID 21086019›Full record

ArticleInvestigational new drugs2012

The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL.

Francesco Carinci, Lorenzo Monasta, Corrado Rubini, Daniela Stramazzotti, Annalisa Palmieri, Elisabetta Melloni, Alex Knowles, Luca Ronfani, Giorgio Zauli, Paola Secchiero

Abstract read
PubMed Publisher
In one paragraph

Article in Investigational new drugs, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Francesco CarinciDepartment of DMCCC, Section of Maxillo-Facial Surgery, University of Ferrara, Ferrara, Italy.
Lorenzo Monasta
Corrado Rubini
Daniela Stramazzotti
Annalisa Palmieri
Elisabetta Melloni
Alex Knowles
Luca Ronfani
Giorgio Zauli
Paola Secchiero
IRCCS Materno Infantile Burlo Garofolo · ITUniversity of Ferrara · ITMarche Polytechnic University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAged, 80 and overAntineoplastic AgentsApoptosisBiomarkers, TumorCarcinoma, Squamous CellFemaleFlow CytometryHL-60 CellsHumansImmunohistochemistryMaleMiddle AgedMouth NeoplasmsPredictive Value of TestsAntineoplastic AgentsBiomarkers, TumorRecombinant ProteinsTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, human

Identifiers

PMID21086019
OpenAlexW2056328552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.